Companies Z Factor

Building treatments for alpha-1 antitrypsin deficiency


Z Factor was a drug discovery company identifying and developing therapeutic agents to treat alpha-1-antitrypsin deficiency.

The company was acquired by Centessa Pharmaceuticals in January 2021.

Cambridge Innovation Capital is a leading Series A investor in the Cambridge ecosystem.

We were born out of a unique relationship with the University of Cambridge and we maintain privileged access to its most inspiring ideas and people in life sciences and deep tech.

Discover more


Read More